PACSHEALTH DoseMonitor® System First to Integrate National Institutes of Health Computed Tomography Dosimetry System
SCOTTSDALE, AZ, September 19, 2016 – PACSHealth, LLC, a developer of medical imaging software, said today that under an agreement with the National Institutes of Health (NIH) National Cancer Institute (NCI), its DoseMonitor® application will be the first software application worldwide to incorporate the NCI dosimetry system for computed tomography (NCICT) for patient radiation dose monitoring. DoseMonitor automates the collection and reporting of medical imaging radiation dose indices to meet regulatory and operational compliance requirements in the US and abroad.
PHS Technologies Group, LLC Partners with Virtual Phantoms, Inc. to Improve Patient Radiation Dose Monitoring.
July 10th , 2015 — PHS Technologies Group, LLC, a division of PACSHealth, LLC, a developer of innovative software that records and analyzes ionizing radiation data from medical imaging procedures, announced today that it will integrate VirtualDose™CT software from Virtual Phantoms Inc. into their industry leading dose monitoring product DoseMonitor®.
Radiology Partners Selects DoseMonitor as its state-of-the-art Radiation Dose Monitoring Solution
May 29, 2015 — PHS Technologies Group LLC, a division of PACSHealth, LLC and developer of innovative software that records and analyzes ionizing radiation data from medical imaging procedures, announced today that Radiology Partners, the largest hospital-based radiology group in the US, will begin offering PHSTG’s DoseMonitor® to monitor patient radiation exposure.
Nuvodia Selects DoseMonitor as its Radiation Dose Monitoring Solution of Choice
March 30 2015 — PHS Technologies Group LLC, a division of PACSHealth, LLC and developer of innovative software that records and analyzes ionizing radiation data from medical imaging procedures, announced today that national radiology solutions & services provider Nuvodia will begin offering PHSTG’s DoseMonitor® 2.0 to monitor patient radiation exposure.